开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2024-08-02 fyzsq 来自广东省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：4.30 submitted
5.4 under review
5.5 under review
6.12 major revision
7.3 Revision Submitted to Journal
7.4 with editor
7.6 under review
7.19 Required Reviews Completed
7.20 minor revision
7.21 Revision Submitted to Journal
7.22 with editor
7.31accept
7.31 online

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2022-08-29 suocao

审稿速度:2.0
经验分享：Article history:
Received 24 June 2022
Revised 8 August 2022
Accepted 9 August 2022
Available online 11 August 2022

78 0

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

模式图一般放在讨论中展示还是放在结果部分？

92 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2021-12-27 学医的彭于晏

想要做但未做的实验是否可以放到讨论中？

81 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2020-03-13 ms5534528927444041

审稿速度:1.0
经验分享：第一次投稿，
2020.2.8日投稿，
2020.3.6日返修，
2020.3.9日修回，
2020.3.10日接收，
杂志效率高啊

200 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2019-09-18 12263d8am82暂无昵称

审稿速度:3.0 | 投稿命中率:25.0
经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！

190 0

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2019-09-10 ms5047990432985118

编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。

175 0

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2019-08-06 宝杰

审稿速度:3.0 | 投稿命中率:50.0
经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。
我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385.
大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。

180 0

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2019-04-22 19846992146e

审稿速度:6.0 | 投稿命中率:50.0
经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来
2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据
3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。

223 0

[GetPortalCommentsPageByObjectIdResponse(id=2218192, encodeId=0cb422181929d, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：4.30 submitted 5.4 under review 5.5 under review 6.12 major revision 7.3 Revision Submitted to Journal 7.4 with editor 7.6 under review 7.19 Required Reviews Completed 7.20 minor revision 7.21 Revision Submitted to Journal 7.22 with editor 7.31accept 7.31 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f65b2375068, createdName=fyzsq, createdTime=Fri Aug 02 18:47:32 CST 2024, time=2024-08-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1241871, encodeId=ecf312418e125, content=审稿速度:2.0 经验分享：Article history: Received 24 June 2022 Revised 8 August 2022 Accepted 9 August 2022 Available online 11 August 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c9c1716883, createdName=suocao, createdTime=Mon Aug 29 17:35:08 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092755, encodeId=e8d11092e551f, content=模式图一般放在讨论中展示还是放在结果部分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092756, encodeId=e8ed1092e568e, content=想要做但未做的实验是否可以放到讨论中？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858350, encodeId=994a858350fe, content=审稿速度:1.0 经验分享：第一次投稿， 2020.2.8日投稿， 2020.3.6日返修， 2020.3.9日修回， 2020.3.10日接收， 杂志效率高啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5995414063, createdName=ms5534528927444041, createdTime=Fri Mar 13 12:39:06 CST 2020, time=2020-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576522, encodeId=b3295e652269, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：刚中一篇，编辑很认真负责，审稿人两个，审稿意见很中肯！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=190, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f232327956, createdName=12263d8am82暂无昵称, createdTime=Wed Sep 18 00:00:00 CST 2019, time=2019-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853680, encodeId=7d4c853680aa, content=编辑效率高，审稿速度快，三个审稿人，两个小修一个大修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79425414132, createdName=ms5047990432985118, createdTime=Tue Sep 10 14:58:33 CST 2019, time=2019-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574483, encodeId=d70c5e448391, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：JCA 作为老牌杂志，审稿很严谨，投稿多次，一般只要有一个审稿人提出有说服力的拒稿理由，那编辑肯定拒了。 我这篇文章一年时间写完，投稿三次，反复修改，两年后才中，而且得是四个审稿人都买账。Wu W, Zhang Y, Zhang F, et al. An analytical strategy for accurate, rapid and sensitive quantitative analysis of isoflavones in traditional Chinese medicines using ultra-high performance supercritical fluid chromatography: take Radix Puerariae as an example[J]. Journal of Chromatography A, 2019: 460385. 大家投稿也不要怕拒绝，即使没中，按审稿意见修改也能大幅度提高文章质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a562084855, createdName=宝杰, createdTime=Tue Aug 06 12:12:00 CST 2019, time=2019-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569877, encodeId=9f7e5698e7de, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：1.这个期刊的编辑真的很细心，英语上的小错误都会给你指出来 2.创新性，只要有创新性编辑一般不会拒稿，会给你一定的时间来进行修稿和补充数据 3.2018年4月份投的稿子，9月份给的审稿意见，由于解决的是一个同行研究忽略了十几年的问题，虽然是简单的仪器，但是从理论上做了一些修改，编辑还是给了很大的肯定，不过由于英语犯了低级的错误，被编辑“说了一通”，审稿时间跨度长，后来编辑给了说法，是审稿人不好找，三个审稿人，其中两个是接收，另外一个提了21条意见，没说接收也没说拒稿，庆幸的是肯定了创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fda1729527, createdName=19846992146e, createdTime=Mon Apr 22 13:37:00 CST 2019, time=2019-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850651, encodeId=83118506518a, content=审稿速度:2.0 经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07165414144, createdName=ms4573613856522007, createdTime=Thu Apr 04 14:33:36 CST 2019, time=2019-04-04, status=1, ipAttribution=)]

2019-04-04 ms4573613856522007

审稿速度:2.0
经验分享：色谱领域的一个经典期刊，还是不错的，审稿人给的意见也很中肯，对我论文的帮助很大，同时也希望期刊也越办越好！

167 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务